These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 18822689
41. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. Hennig M, Yip-Schneider MT, Klein P, Wentz S, Matos JM, Doyle C, Choi J, Wu H, O'Mara A, Menze A, Noble S, McKillop IH, Schmidt CM. J Surg Res; 2009 Jun 15; 154(2):187-95. PubMed ID: 19321179 [Abstract] [Full Text] [Related]
42. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Wen-Sheng W. Oncogene; 2003 Feb 20; 22(7):955-63. PubMed ID: 12592382 [Abstract] [Full Text] [Related]
43. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. Das R, Mahabeleshwar GH, Kundu GC. J Biol Chem; 2004 Mar 19; 279(12):11051-64. PubMed ID: 14704150 [Abstract] [Full Text] [Related]
44. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. Huang S, New L, Pan Z, Han J, Nemerow GR. J Biol Chem; 2000 Apr 21; 275(16):12266-72. PubMed ID: 10766865 [Abstract] [Full Text] [Related]
45. Src/ERK but not phospholipase D is involved in keratinocyte growth factor-stimulated secretion of matrix metalloprotease-9 and urokinase-type plasminogen activator in SNU-16 human stomach cancer cell. Shin EY, Ma EK, Kim CK, Kwak SJ, Kim EG. J Cancer Res Clin Oncol; 2002 Nov 21; 128(11):596-602. PubMed ID: 12458339 [Abstract] [Full Text] [Related]
46. P38 MAPK pathway is involved in the urokinase plasminogen activator expression in human gastric SNU-638 cells. Shin BA, Yoo HG, Kim HS, Kim MH, Hwang YS, Chay KO, Lee KY, Ahn BW, Jung YD. Oncol Rep; 2003 Nov 21; 10(5):1467-71. PubMed ID: 12883725 [Abstract] [Full Text] [Related]
51. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T. Int J Cancer; 2002 Dec 01; 102(4):379-89. PubMed ID: 12402308 [Abstract] [Full Text] [Related]
52. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K. Hepatology; 2002 May 01; 35(5):1117-24. PubMed ID: 11981761 [Abstract] [Full Text] [Related]
54. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF. Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586 [Abstract] [Full Text] [Related]
56. Targeting cap-dependent translation to inhibit Chikungunya virus replication: selectivity of p38 MAPK inhibitors to virus-infected cells due to autophagy-mediated down regulation of phospho-ERK. Mudaliar P, Pradeep P, Abraham R, Sreekumar E. J Gen Virol; 2021 Jul 15; 102(7):. PubMed ID: 34328830 [Abstract] [Full Text] [Related]
60. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. Tsukada Y, Miyazawa K, Kitamura N. J Biol Chem; 2001 Nov 02; 276(44):40968-76. PubMed ID: 11533045 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]